Cultural Sensitivity and Challenges in Management of the Transgender Patient With End-Stage Renal Disease in Transplantation

    March 2016 in “ Progress in Transplantation ”
    Deborah Ann Hoch, Maya Bulman, Dorn W. McMahon
    Image of study
    TLDR Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.
    The article from 2016 discusses the complexities of managing transgender patients with end-stage renal disease (ESRD) in the context of transplantation. It underscores the need for cultural sensitivity and comprehensive understanding of the healthcare needs specific to transgender individuals. The article points out the lack of provider knowledge and acceptance as a significant barrier to care and recommends accurate documentation of demographic information, healthcare records, chosen name, and gender identity. It also emphasizes the importance of considering the patient's health and medical history, surgical history, insurance coverage, physical examination, and psychological evaluation. The article notes the high rates of psychiatric comorbidities among transgender individuals and the potential psychiatric side effects of gender affirmation surgery and hormonal therapy. It stresses the need for a multidisciplinary approach to care, including mental health providers, to address the risks associated with hormone therapy and immunosuppression, such as new-onset diabetes after transplantation (NODAT) and venous thromboembolic disease. The article concludes that thorough evaluation, management, education, and cultural sensitivity are essential for achieving optimal outcomes for transgender patients with ESRD undergoing transplantation.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 518 results

      community 5 months of nuking T, 2 months of minoxidil

      in Transgender  485 upvotes 3 months ago
      The user transitioned from finasteride to Cyproterone and started using Minoxidil, resulting in healthier hair and regrowth. They plan to wean off Minoxidil in a year, depending on regrowth.

      community What was your “f*ck I’m balding” story?

      in Chat  178 upvotes 1 year ago
      User noticed thinning hair at 18-19, started finasteride at 22 and minoxidil at 24, with positive results. Others shared hair loss experiences and treatments, including finasteride, minoxidil, and hair transplants.

      community Ultimate Stack without nuking your gender (you'll go broke)

      in Treatment  79 upvotes 3 weeks ago
      A hair loss treatment plan includes finasteride, dutasteride, RU58841, pyrilutamide, minoxidil, and microneedling to inhibit DHT and promote hair growth. It also recommends supplements like Reishi and Lion’s Mane mushrooms, and a shampoo with ketoconazole, caffeine, and melatonin.

      community Progress: 1 year mtf hrt, 9 months Min/Fin

      in Transgender  116 upvotes 3 weeks ago
      The user experienced significant hair regrowth after one year on male-to-female hormone replacement therapy (HRT) and nine months using minoxidil and finasteride. They noted a reduction in body hair and attributed much of the hair regrowth to the addition of minoxidil.

      community Discussion on Finasteride and life.

      in Chat  164 upvotes 2 months ago
      Finasteride can aid hair regrowth but may cause side effects like depression and sexual dysfunction. Users discuss experiences with finasteride, minoxidil, and RU58841, highlighting varied responses and the importance of informed treatment choices.

    Similar Research

    5 / 1000+ results